Role of CD4⁺CD25⁺ Regulatory T Cells in Melatonin‐Mediated Inhibition of Murine Gastric Cancer Cell Growth In Vivo and In Vitro

Abstract

Melatonin is an important immune modulator with antitumor functions, and increased CD4 þ CD25 þ regulatory T cells (Tregs) have been observed in tumor tissues of patients and animal models with gastric cancer. However, the relationship between melatonin and Tregs remains unclear. To explore this potential connection, we performed an in vivo study by inoculating the murine foregastric carcinoma (MFC) cell line in mice and then treated them with different doses of melatonin (0, 25, 50, and 100 mg/kg, i.p.) for 1 week. The results showed that melatonin could reduce the tumor tissue and decrease Tregs numbers and Forkhead box p3 (Foxp3) expression in the tumor tissue. An in vitro study was also performed to test the effects of purified Tregs on melatonin-mediated inhibition of MFC cells. The cell cultures were divided into three groups: 1) MFCþ Tregs; 2) MFC only; and 3) MFCþCD4 þ CD25 À T cells. After treatment with different concentrations of melatonin (0, 2, 4, 6, 8, and 10 mM) for 24 h, a dose-dependent apoptosis and cell cycle arrest at the G2/M phase was detected in melatonin-treated MFC at melatonin concentration higher than 4 mM. There were no significant differences in the rates of apoptosis and cell cycle distributions of MFC among the three groups. In conclusion, the antigastric cancer effect of melatonin is associated with downregulation of CD4 þ CD25 þ Tregs and its Foxp3 expression in the tumor tissue. Anat Rec, 294:781-788, 2011. V V C 2011 Wiley-Liss, Inc.

Melatonin modulates adiponectin expression on murine colitis with sleep deprivation

“…A preliminary study has highlighted the in vivo inhibitory actions of melatonin on Treg cell generation in cancer patients[34]. It has been reported that in vivo administration of melatonin to mice subjected to experimental cancer has down regulation of CD4+CD25+ Treg cells and Foxp3 expression in tumor tissues[35]. These results suggest that melatonin may have adjuvant effect in inhibiting colitis associated cancer development in patients with IBD.…”

Melatonin-Induced Oncostasis, Mechanisms and Clinical Relevance

“…Indeed, IL-2 is fundamental as a growth factor for T lymphocytes, with these cells playing an essential role in the generation of an effective anticancer immunity. Also, melatonin decreases expression of CD4+ CD25+ regulatory T cells and Foxp3 in tumor tissue [80].…”

The melatonin immunomodulatory actions in radiotherapy

“…So, several experiments were aimed at increasing cytotoxic T cells and decreasing Tregs in tumor tissue. Liu et al (2011) showed that melatonin can reduce Tregs numbers in the tumor tissues of patients and also animal in vivo models with gastric cancer.…”